InvestorsHub Logo
Followers 32
Posts 2803
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Thursday, 10/12/2017 2:02:15 AM

Thursday, October 12, 2017 2:02:15 AM

Post# of 5918
SNO2017 abstract title: ''ACTR-56 A 2-part safety and exploratory efficacy randomised double-blind, placebo controlled study of a 1:1 ratio of cannabidiol and delta9tetrahydrocannabinol (CBD:THC) plus dose-intense temozolomide in patients with recurrent glioblastoma multiforme (GBM).'' https://www.soc-neuro-onc.org/UploadedFiles/2017_SNO_Preliminary_Program.pdf